Roche ĂŒbertrifft den Branchenindex dank wachsender Therapien ...
Der Kampf gegen Ăbergewicht wird zunehmend medikalisiert. ...
Roche strengthens its diagnostics division with FDA-approved ...
Roche erhĂ€lt FDA-Freigabe fĂŒr Hochleistungs-AnalysegerĂ€te ...
AnĂĄlisis del sector salud: Roche fortalece diagnĂłsticos ...
Roche erhĂ€lt FDA-Freigabe fĂŒr HochdurchsatzgerĂ€te in ...
AEVIS VICTORIA SA (AEVS) - Infracore SA - See-Spital renforce ...
AEVIS VICTORIA SA (AEVS) - Infracore SA - See-Spital strengthens ...
AEVIS VICTORIA SA (AEVS) - Infracore SA - See-Spital stÀrkt ...
Roche bringt einen neuen Labortest auf den Markt der HIV ...
Roche's trastuzumab capecitabine and tucatinib combo more ...
VanEck Developed Markets Dividend Leaders ETF shows strong ...
Roche defends profits via AI and efficiency as European ...
Roche sieht sein profitables GeschÀftsmodell durch hohe ...
Roches Alzheimer-Wirkstoff Trontinemab entfernt dank Brainshuttle-Technologie ...
Europa Schluss: RĂŒckschlag nach Erholung - SMI verliert ...
Aktien Europa Schluss: RĂŒckschlag nach Erholung - SMI verliert ...
Der europÀische Aktienmarkt wird Ende MÀrz 2026 von der ...
Nvidia reporta ingresos récord y anuncia retribución del ...
Roche partners with Nvidia to deploy over 3 500 AI GPUs ...
Ams Osram led the Swiss market with an 11.06% surge breaking ...
Die Schweizerische Nationalbank hÀlt die Zinsen stabil ...
NVIDIA orchestriert den globalen Rollout der Blackwell-Architektur ...
Roche launches automated organoid institute and new diagnostic ...
Roche stÀrkt seine Pipeline mit einer 100-Millionen-Investition ...
Der ETF bildet die 20 bedeutendsten Schweizer Aktien physisch ...
Newron reports 2025 results extends EIB debt to 2028 and ...
Roche fĂŒhrt ein neues Diagnostiksystem fĂŒr bis zu 25 Erreger ...
Keine FĂŒhrungswechsel beim Weltwirtschaftsforum in Davos ...
Der Schweizer Aktienmarkt erholt sich von geopolitischen ...
NVIDIA positioniert sich mit einer vollstÀndigen Plattform ...
Roche beendet die klinische Entwicklung von Emugrobart fĂŒr ...
A pesar de récords de ventas con Mounjaro y Zepbound la ...
Eli Lilly shares fall despite blockbuster Q4 results. Investors ...
Newron enters a pivotal phase with its 2025 annual report ...
Siemens Healthineers advances Alzheimer's blood tests but ...
BioNTech busca autorizaciĂłn en EE.UU. en 2026 para su fĂĄrmaco ...
Der breit diversifizierte Europa-ETF verzeichnet starke ...
Roche presents promising Alzheimer s & Parkinson s data ...
Der Investment Trust setzt auf ein konzentriertes Portfolio ...
Roche reports strong Phase III lupus data for Gazyva and ...
Nvidia doubles chip revenue forecast to $1 trillion but ...
BioNTech spins off its mRNA business into a separate entity ...
BioNTech separa su unidad de ARN mensajero en una nueva ...
La revisiĂłn al alza de ingresos para sus chips de IA contrasta ...
Roche Diagnostics erhĂ€lt europĂ€ische Zulassung fĂŒr einen ...
EQS-HV: HELLA GmbH & Co. KGaA: Bekanntmachung der Einberufung ...
Microfluidics Market to Reach $77.5 Billion Globally by ...
Drug Abuse Testing Market to Reach $8.9 billion Globally ...
Chemiluminescence Immunoassay Market worth $16.39 billion ...
Drug Screening Market worth $21.29 billion by 2030 | MarketsandMarketsâą ...
Head and Neck Cancer Therapeutics Market to Reach USD 2.6 ...
LA ROCHE-POSAY PARTECIPA ALLA 38ÂȘ EDIZIONE DELL AMERICA ...
Roche receives CE mark for first IVD immunoassay blood test ...
Head and Neck Cancer Therapeutics Market to Reach USD 2.6 ...
Drug Screening Market worth $21.29 billion by 2030 | MarketsandMarketsâą ...
Checkpoint Inhibitor Refractory Cancer Drugs Market to Reach ...
Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven ...
Blood Glucose Monitoring Devices Market to Reach USD 36.8 ...
Roche receives CE mark for first IVD immunoassay blood test ...
Growth Factors Market to Reach US$ 3.7 Bn by 2033 Expands ...
Growth Factors Market to Reach US$ 3.7 Bn by 2033 Expands ...
Roche receives CE mark for first IVD immunoassay blood test ...
Growth Factors Market to Reach US$ 3.7 Bn by 2033 Expands ...
LA ROCHE-POSAY PARTECIPA ALLA 38ÂȘ EDIZIONE DELL AMERICA ...
LA ROCHE-POSAY PARTECIPA ALLA 38ÂȘ EDIZIONE DELL AMERICA ...
La Roche-Posay se une a la 38ÂȘ Copa AmĂ©rica como socio ...
The VanEck Morningstar Developed Markets Dividend Leaders ...
Growth Factors Market to Reach US$ 3.7 Bn by 2033 Expands ...
Drug Abuse Testing Market to Reach $8.9 billion Globally ...
Blood Glucose Monitoring Devices Market to Reach USD 36.8 ...
Viral Vectors and Plasmid DNA Manufacturing Market to Reach ...
LA ROCHE-POSAY PARTECIPA ALLA 38ÂȘ EDIZIONE DELL AMERICA ...
Roche receives CE mark for first IVD immunoassay blood test ...
Growth Factors Market to Reach US$ 3.7 Bn by 2033 Expands ...
Growth Factors Market to Reach US$ 3.7 Bn by 2033 Expands ...
Growth Factors Market to Reach US$ 3.7 Bn by 2033 Expands ...
Drug Screening Market worth $21.29 billion by 2030 | MarketsandMarketsâą ...
Head and Neck Cancer Therapeutics Market to Reach USD 2.6 ...
Checkpoint Inhibitor Refractory Cancer Drugs Market to Reach ...
LA ROCHE-POSAY JOINS THE 38TH AMERICA'S CUP AS TITLE PARTNER ...
Hematologic Malignancies Market to Reach USD 128.48 Billion ...
Blood Glucose Monitoring Devices Market to Reach USD 36.8 ...
Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven ...
Chemiluminescence Immunoassay Market worth $16.39 billion ...
La Roche-Posay se une a la 38ÂȘ Copa AmĂ©rica como socio ...
Drug Abuse Testing Market to Reach $8.9 billion Globally ...
Drug Abuse Testing Market to Reach $8.9 billion Globally ...
Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven ...
Chemiluminescence Immunoassay Market worth $16.39 billion ...
Roche receives CE mark for first IVD immunoassay blood test ...
Blood Glucose Monitoring Devices Market to Reach USD 36.8 ...
Chemiluminescence Immunoassay Market worth $16.39 billion ...
Viral Vectors and Plasmid DNA Manufacturing Market to Reach ...
Growth Factors Market to Reach US$ 3.7 Bn by 2033 Expands ...
Drug Abuse Testing Market to Reach $8.9 billion Globally ...